Novartis joins seven global companies to found the Value Balancing Alliance

A new AI-enabled disease management tool in China aims to improve the lives of millions of patients with heart failure.

Novartis data at 2019 ASH and SABCS underscore our evolving R&D approach in innovative platforms to reimagine medicine and help improve patient outcomes.

We are partnering with the Friedrich Miescher Institute on more than 50 research projects to improve and extend people’s lives.

It’s time to change the conversation. Patient inspired and community led, Sound Up aims to empower people affected by lung cancer in raising the volume to vocally self-advocate.

Despite advancements in care, prostate cancer is one of the most frequently diagnosed cancers around the world. This Movember, we’re focused on raising awareness of prostate cancer.

Novartis is working with partners around the world to help eliminate preventable visual impairment and blindness by reimagining access to eye care.